Stay updated with breaking news from Equity Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It's fair to say C4X Discovery had a fantastic start with the shares advancing 113 per cent after drug giant AstraZeneca delivered an $11million post-Christmas windfall.
It's fair to say C4X Discovery had a fantastic start with the shares advancing 113 per cent after drug giant AstraZeneca delivered an $11million post-Christmas windfall.
Mr. Ambassador, in the run up to the recent u. S. China strategic and economic dialogue, there were a lot of press reports of the several issues that would be on the table. One of those included the ongoing solar panel dispute and resulting poly silicone tariffs from china. However in the fact sheets that came out, theres emphasis on steel and some of the other issues. But i saw no mention of the solar issue. I was just wondering if you could give us a status report on where that stands. Thank you. We did discuss it while i was there. Weve continued to discuss the issue. Its a long standing ou...
What could drive Impax shares? Global warming, ‘authenticity,’ and sheer cheapness.
Hercules Site Services ahead of FY23 expectations + strong growth trajectory, say analysts